Literature DB >> 18464111

Socio-economic deprivation and survival of non-Hodgkin lymphoma in Scotland.

Caroline Bray1, David S Morrison, Pam McKay.   

Abstract

Socio-economic deprivation is known to be associated with poorer survival from non-Hodgkin lymphoma (NHL) but routine data have not been able to determine whether this can be explained by differences in disease severity at presentation. We examined survival in all patients diagnosed with NHL in Scotland between 1979 and 1996 and between 1994 and 1996 used Scotland and Newcastle Lymphoma Group data, which include detailed clinical staging information. Compared with individuals from the most affluent areas, survival is 10% poorer in intermediate, and 19% poorer in patients living in the most deprived areas. Deprivation is associated with more B symptoms and poorer performance status but not with other indicators of more advanced disease, suggesting that the disease may be more aggressive or immunocompetence poorer among more deprived populations. We also noted improvements in relative survival from NHL over time.

Entities:  

Mesh:

Year:  2008        PMID: 18464111     DOI: 10.1080/10428190801933377

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  9 in total

1.  Vegetable and fruit intake and non-Hodgkin lymphoma survival in Connecticut women.

Authors:  Xuesong Han; Tongzhang Zheng; Francine Foss; Theodore R Holford; Shuangge Ma; Ping Zhao; Min Dai; Christopher Kim; Yaqun Zhang; Yana Bai; Yawei Zhang
Journal:  Leuk Lymphoma       Date:  2010-06

2.  Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.

Authors:  Mark A Fiala; Joseph D Finney; Jingxia Liu; Keith E Stockerl-Goldstein; Michael H Tomasson; Ravi Vij; Tanya M Wildes
Journal:  Leuk Lymphoma       Date:  2015-03-08

3.  Neighborhood socioeconomic status influences the survival of elderly patients with myelodysplastic syndromes in the United States.

Authors:  Rong Wang; Cary P Gross; Stephanie Halene; Xiaomei Ma
Journal:  Cancer Causes Control       Date:  2009-05-20       Impact factor: 2.506

4.  Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma.

Authors:  Erin E Kent; Rebecca A Morris; Joan A Largent; Argyrios Ziogas; Leonard S Sender; Hoda Anton-Culver
Journal:  J Cancer Epidemiol       Date:  2010-06-22

5.  Socioeconomic position, treatment, and survival of non-Hodgkin lymphoma in Denmark--a nationwide study.

Authors:  B L Frederiksen; S O Dalton; M Osler; M Steding-Jessen; P de Nully Brown
Journal:  Br J Cancer       Date:  2012-02-07       Impact factor: 7.640

6.  The care center influences the management of lymphoma patients in a universal health care system: an observational cohort study.

Authors:  S Lamy; C Bettiol; P Grosclaude; G Compaci; G Albertus; C Récher; J C Nogaro; F Despas; G Laurent; C Delpierre
Journal:  BMC Health Serv Res       Date:  2016-08-02       Impact factor: 2.655

7.  Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.

Authors:  Harry Comber; Marianna De Camargo Cancela; Trutz Haase; Howard Johnson; Linda Sharp; Jonathan Pratschke
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

8.  A French multicentric prospective prognostic cohort with epidemiological, clinical, biological and treatment information to improve knowledge on lymphoma patients: study protocol of the "REal world dAta in LYmphoma and survival in adults" (REALYSA) cohort.

Authors:  Hervé Ghesquières; Cédric Rossi; Fanny Cherblanc; Sandra Le Guyader-Peyrou; Fontanet Bijou; Pierre Sujobert; Pascale Fabbro-Peray; Adeline Bernier; Aurélien Belot; Loic Chartier; Luc-Matthieu Fornecker; Isabelle Baldi; Krimo Bouabdallah; Camille Laurent; Lucie Oberic; Nadine Morineau; Steven Le Gouill; Franck Morschhauser; Corinne Haioun; Gandhi Damaj; Stéphanie Guidez; Gaëlle Labouré; Olivier Fitoussi; Laure Lebras; Rémy Gressin; Gilles Salles; Loïc Ysebaert; Alain Monnereau
Journal:  BMC Public Health       Date:  2021-03-02       Impact factor: 3.295

9.  Excess Mortality by Multimorbidity, Socioeconomic, and Healthcare Factors, amongst Patients Diagnosed with Diffuse Large B-Cell or Follicular Lymphoma in England.

Authors:  Matthew James Smith; Aurélien Belot; Matteo Quartagno; Miguel Angel Luque Fernandez; Audrey Bonaventure; Susan Gachau; Sara Benitez Majano; Bernard Rachet; Edmund Njeru Njagi
Journal:  Cancers (Basel)       Date:  2021-11-19       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.